DCM
ABEO icon

Dupont Capital Management’s Abeona Therapeutics ABEO Stock Holding History

Dupont Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,826
Closed -$148K – 1342
2020
Q1 		$148K Buy
+2,826
New +$189K ﹤0.01% 1094

Other funds holding ABEO

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Dupont Capital Management's ABEO Position: Q2 2020 in Review

Dupont Capital Management sold out of Abeona Therapeutics (ABEO) in Q2 2020, closing a stake of 2,826 shares — an estimated $148K sold.

Dupont Capital Management first reported a position in ABEO in Q1 2020 and held it in 1 quarter. The position peaked at $148K in Q1 2020. 83 funds tracked by Wall St. Rank hold ABEO as of Q2 2020.

  • Dupont Capital Management reported no remaining Abeona Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Dupont Capital Management sold 2,826 Abeona Therapeutics shares in Q2 2020, an estimated $148K.
  • Dupont Capital Management first reported a position in Abeona Therapeutics in Q1 2020 and held it in 1 quarter.
  • Dupont Capital Management's Abeona Therapeutics position peaked at $148K in Q1 2020.
  • 83 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2020.

Based on Dupont Capital Management's 13F filing for Q2 2020, filed 24 Jul 2020.